We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPTN
3426
DELISTED
NEOPHOTONICS CORP
NPTN
$236K ﹤0.01%
23,046
-23,156
-50% -$244K
GSK icon
3427
PUT
GSK
GSK
$103B
$235K ﹤0.01%
4,720
HYEM icon
3428
VanEck Emerging Markets High Yield Bond ETF
HYEM
$521M
$235K ﹤0.01%
+9,861
New +$234K
MAC icon
3429
PUT
Macerich
MAC
$7.34B
$235K ﹤0.01%
12,900
TWI icon
3430
Titan International
TWI
$466M
$234K ﹤0.01%
27,719
-50,134
-64% -$489K
LGF.A
3431
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$234K ﹤0.01%
11,339
+3,978
+54% +$69.6K
CAMP
3432
DELISTED
CalAmp Corp.
CAMP
$234K ﹤0.01%
801
-1,069
-57% -$319K
BMRC icon
3433
Bank of Marin Bancorp
BMRC
$474M
$233K ﹤0.01%
7,315
-10,839
-60% -$379K
NOBL icon
3434
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$233K ﹤0.01%
5,146
-186
-3% -$8.43K
ORRF icon
3435
Orrstown Financial Services
ORRF
$859M
$233K ﹤0.01%
10,077
-11,361
-53% -$274K
UBFO
3436
DELISTED
United Security Bancshares
UBFO
$233K ﹤0.01%
28,444
-9,715
-25% -$78.8K
HAYN
3437
DELISTED
Haynes International, Inc.
HAYN
$233K ﹤0.01%
6,601
-9,054
-58% -$296K
CMLS
3438
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$233K ﹤0.01%
15,858
-781
-5% -$8.27K
VAPO
3439
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$233K ﹤0.01%
1,231
-8,121
-87% -$1.38M
NODK icon
3440
NI Holdings
NODK
$318M
$232K ﹤0.01%
12,282
-6,397
-34% -$123K
YMAB
3441
DELISTED
Y-mAbs Therapeutics
YMAB
$232K ﹤0.01%
6,854
-27,147
-80% -$871K
ZIXI
3442
DELISTED
Zix Corporation
ZIXI
$232K ﹤0.01%
32,986
-12,704
-28% -$92K
LASR icon
3443
nLIGHT
LASR
$3.95B
$231K ﹤0.01%
6,339
-28,020
-82% -$837K
OCUL icon
3444
Ocular Therapeutix
OCUL
$1.84B
$231K ﹤0.01%
16,368
-49,263
-75% -$749K
EVA
3445
DELISTED
Enviva Inc.
EVA
$231K ﹤0.01%
4,418
-363
-8% -$17.9K
STX icon
3446
Seagate
STX
$189B
$229K ﹤0.01%
2,608
-529,335
-100% -$47.7M
KRYS icon
3447
Krystal Biotech
KRYS
$9.25B
$228K ﹤0.01%
3,366
-18,655
-85% -$1.3M
ONCT
3448
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$228K ﹤0.01%
+2,395
New +$284K
CLNE icon
3449
Clean Energy Fuels
CLNE
$410M
$226K ﹤0.01%
22,192
-86,462
-80% -$892K
FPI
3450
Farmland Partners
FPI
$418M
$226K ﹤0.01%
18,787
-15,364
-45% -$197K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.